[go: up one dir, main page]

SE7508789L - Forfarande for framstellnign av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner, deras syraadditionssalter och anvendning som lekemedel - Google Patents

Forfarande for framstellnign av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner, deras syraadditionssalter och anvendning som lekemedel

Info

Publication number
SE7508789L
SE7508789L SE7508789A SE7508789A SE7508789L SE 7508789 L SE7508789 L SE 7508789L SE 7508789 A SE7508789 A SE 7508789A SE 7508789 A SE7508789 A SE 7508789A SE 7508789 L SE7508789 L SE 7508789L
Authority
SE
Sweden
Prior art keywords
benzomorphanes
tetrahydrofurfuryl
disubstituted
medicines
beta
Prior art date
Application number
SE7508789A
Other languages
Unknown language ( )
English (en)
Other versions
SE425392B (sv
Inventor
H Merz
A Langbein
G Walther
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE7508789L publication Critical patent/SE7508789L/sv
Publication of SE425392B publication Critical patent/SE425392B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7508789A 1974-08-05 1975-08-04 Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter SE425392B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SE7508789L true SE7508789L (sv) 1976-02-10
SE425392B SE425392B (sv) 1982-09-27

Family

ID=5922448

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7508789A SE425392B (sv) 1974-08-05 1975-08-04 Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter

Country Status (27)

Country Link
US (1) US3982005A (sv)
JP (1) JPS60358B2 (sv)
AT (1) AT348140B (sv)
BE (1) BE832099R (sv)
BG (3) BG25088A3 (sv)
CA (1) CA1049008A (sv)
CH (7) CH613963A5 (sv)
CS (1) CS189717B2 (sv)
DD (1) DD122685A5 (sv)
DE (1) DE2437610A1 (sv)
DK (1) DK138992C (sv)
ES (6) ES452766A1 (sv)
FI (1) FI63229C (sv)
FR (1) FR2320096A2 (sv)
GB (1) GB1513950A (sv)
HU (1) HU177952B (sv)
IE (1) IE42216B1 (sv)
IL (1) IL47860A (sv)
LU (1) LU73138A1 (sv)
NL (1) NL7509249A (sv)
NO (1) NO143460C (sv)
PH (1) PH13687A (sv)
PL (3) PL99819B1 (sv)
RO (3) RO67390A (sv)
SE (1) SE425392B (sv)
SU (3) SU591147A3 (sv)
ZA (1) ZA754997B (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
ATE554078T1 (de) 2007-07-26 2012-05-15 Vitae Pharmaceuticals Inc Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern
CA2704628C (en) 2007-11-16 2016-11-29 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (en) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5730021B2 (ja) 2008-02-15 2015-06-03 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としてのシクロアルキルラクタム誘導体
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
NZ588954A (en) 2008-05-01 2012-08-31 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009134392A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CL2009001151A1 (es) 2008-05-13 2010-08-13 Boehringer Ingelheim Int Compuestos derivados de acidos carbociclicos aliciclicos de benzomorfanos, procedimiento de preparacion, composicion farmaceutica, utiles para tratar enfermedades influenciadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa, como trastornos metabolicos.
PL2324018T3 (pl) 2008-07-25 2014-02-28 Boehringer Ingelheim Int Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
UY33001A (es) 2009-11-06 2011-05-31 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
WO2013025664A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
KR20230112134A (ko) 2020-11-26 2023-07-26 신에쓰 가가꾸 고교 가부시끼가이샤 실온경화성 오르가노폴리실록산 조성물 및 물품 그리고 가수분해성 오르가노실란 화합물 및 그 제조 방법
EP4397695A4 (en) 2021-09-03 2025-09-10 Shinetsu Chemical Co ORGANOPOLYSILOXANE COMPOUND, ROOM TEMPERATURE CURABLE ORGANOPOLYSILOXANE COMPOSITION AND ARTICLE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (sv) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166804B2 (sv) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
IL47860A (en) 1979-01-31
BG25090A3 (bg) 1978-07-12
ES452763A1 (es) 1977-10-01
CH616420A5 (sv) 1980-03-31
BG25089A3 (bg) 1978-07-12
DK352875A (da) 1976-02-06
FI752211A7 (sv) 1976-02-06
ES452765A1 (es) 1977-10-16
SU587859A3 (ru) 1978-01-05
PL99819B1 (pl) 1978-08-31
JPS60358B2 (ja) 1985-01-07
DD122685A5 (sv) 1976-10-20
ES452766A1 (es) 1977-10-01
NO143460C (no) 1981-02-18
BG25088A3 (bg) 1978-07-12
ATA523775A (de) 1978-06-15
ZA754997B (en) 1977-04-27
BE832099R (fr) 1976-02-04
FR2320096A2 (fr) 1977-03-04
AT348140B (de) 1979-01-25
CH615677A5 (sv) 1980-02-15
CH615679A5 (sv) 1980-02-15
AU8364675A (en) 1977-02-10
DK138992B (da) 1978-11-27
PL99816B1 (pl) 1978-08-31
DE2437610A1 (de) 1976-02-26
NO143460B (no) 1980-11-10
NO752731L (sv) 1976-02-06
CA1049008A (en) 1979-02-20
CH615678A5 (sv) 1980-02-15
CH615680A5 (sv) 1980-02-15
ES452768A1 (es) 1977-10-01
SU587858A3 (ru) 1978-01-05
CH613963A5 (sv) 1979-10-31
RO72735A (ro) 1982-09-09
LU73138A1 (sv) 1977-04-13
ES452764A1 (es) 1977-10-16
IE42216L (en) 1976-02-05
DK138992C (da) 1979-04-30
FI63229B (fi) 1983-01-31
RO72736A (ro) 1982-09-09
SE425392B (sv) 1982-09-27
PL99838B1 (pl) 1978-08-31
CS189717B2 (en) 1979-04-30
FR2320096B2 (sv) 1978-09-01
HU177952B (en) 1982-02-28
CH616421A5 (sv) 1980-03-31
IE42216B1 (en) 1980-07-02
IL47860A0 (en) 1975-11-25
ES452767A1 (es) 1977-10-01
NL7509249A (nl) 1976-02-09
FI63229C (fi) 1983-05-10
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
US3982005A (en) 1976-09-21
JPS5139673A (en) 1976-04-02
SU591147A3 (ru) 1978-01-30
GB1513950A (en) 1978-06-14

Similar Documents

Publication Publication Date Title
SE7508789L (sv) Forfarande for framstellnign av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner, deras syraadditionssalter och anvendning som lekemedel
NO149888C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-substituerte-2`-hydroksyl-6,7-benzomorfaner og syreaddisjonssalter derav
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
SE7711168L (sv) Nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner och forfarande for deras framstellning
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
ES431057A1 (es) Procedimiento para la preparacion de nuevos n-(metoximetil - furilmetil)-6, 7-benzomorfanos y -morfinanos.
ES431510A1 (es) Procedimiento para la preparacion de 2 - (heteroaril-metil)-5,9 beta - dialcohil-6,7-benzomorfanos.
SE7709865L (sv) Nya fenyletylaminer och forfarande for framstellning derav
NO142400C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye benzimidazolinon-derivater
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
SE7409183L (sv) Forfarande for frasmtellning av tricykliskt substituerade aminoalkoholer och icke-toxiska salter derav.
SE7901405L (sv) Nya substituerade 2-fenylimino-imidazolidiner och deras syraadditionssaltersamt lekemedel innehallande dessa foreningar och forfarande for framstellning derav
SE7709158L (sv) Nya substituerade 2-fenylaminoimidazolin-(2)-er, syraadditionssalter derav, lekemedel som innehaller dessa och forfarande for framstellning derav
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7702668L (sv) Nya stilbenforeningar och forfarande for deras framstellning
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
GB1471847A (en) Dibenzofuran derivatives
SE7902302L (sv) Nya n-fenylalaninderivat, deras framstellning och deras anvendning som lekemedel
SE7608592L (sv) Nya homoftalimider
ES425015A1 (es) Procedimiento para la preparacion de n-(heteroaril-metil)- 6,14-endoeteno-7alfa-hidroxialcohil - tetrahidro - nororipa-vinas y tebainas.
ES424309A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil)-7 -acil-6,14-endoetenotetrahidronororipavinas y -tebainas.
GB1124261A (en) Naphthofuran derivatives
SE7709816L (sv) Nya aryl-alkylaminer och forfarande for framstellning derav
FI803969L (fi) Nya substituerade 2-fenylamino-imidazoliner-(2) deras syraadditionssalter dessa innehaollande laekemedel och foerfarande foer deras framstaellning

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7508789-0

Effective date: 19890911

Format of ref document f/p: F